Simultaneous quantification of siRNA antisense and sense strands by hybrid liquid chromatography-mass spectrometry
Rattachement africain : us, il. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: Most oligonucleotide bioanalytical assays currently only quantify the pharmacologically-active antisense strand, though there have been recent efforts to simultaneously quantify the sense strand using hybridization ELISA or solid phase extraction LC-MS. Hybrid LC-MS, which offers both high sensitivity and specificity unlike the currently used platforms, has not been applied to quantify both siRNA strands simultaneously. MATERIALS & METHODS: A hybrid LC-MS assay utilizing LNA capture probes was developed and applied to quantify both strands of a 21-mer lipid-conjugated siRNA (SIR-3) using tandem mass spectrometry (MS/MS). A similar approach using high-resolution mass spectrometry (HRMS) was also evaluated. RESULTS: The final LC-MS/MS method was capable of quantifying both strands of SIR-3 at concentrations between 0.600 and 1000 ng/mL in cynomolgus monkey tissue homogenates with acceptable accuracy and precision. The LC-HRMS assay demonstrated similar sensitivity and assay performance as the LC-MS/MS assay. CONCLUSIONS: Overall, this manuscript presents orthogonal methods to existing siRNA bioanalytical workflows that with high sensitivity and specificity can provide greater information about the concentration and biotransformation of an siRNA analyte.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Simultaneous quantification of siRNA antisense and sense strands by hybrid liquid chromatography-mass spectrometry
- Date Crossref
- 31/01/2025
- Éditeur
- Informa UK Limited
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Johnson & Johnson (United States) pays non établi dans la noticeEntreprise
-
Johnson & Johnson (Israel) pays non établi dans la noticeEntreprise
-
Bioanalysis Discovery & Development Sciences pays non établi dans la noticeInstitution
-
Translational PK/PD & Investigative Toxicology pays non établi dans la noticeInstitution
Johnson & Johnson (United States), Johnson & Johnson (Israel) et Bioanalysis Discovery & Development Sciences, avec 1 autre affiliation.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.